GNE-781, A Highly Advanced Potent and Selective Bromodomain Inhibitor of Cyclic Adenosine Monophosphate Response Element Binding Protein, Binding Protein (CBP).
Romero, F.A., Murray, J., Lai, K.W., Tsui, V., Albrecht, B.K., An, L., Beresini, M.H., de Leon Boenig, G., Bronner, S.M., Chan, E.W., Chen, K.X., Chen, Z., Choo, E.F., Clagg, K., Clark, K., Crawford, T.D., Cyr, P., de Almeida Nagata, D., Gascoigne, K.E., Grogan, J.L., Hatzivassiliou, G., Huang, W., Hunsaker, T.L., Kaufman, S., Koenig, S.G., Li, R., Li, Y., Liang, X., Liao, J., Liu, W., Ly, J., Maher, J., Masui, C., Merchant, M., Ran, Y., Taylor, A.M., Wai, J., Wang, F., Wei, X., Yu, D., Zhu, B.Y., Zhu, X., Magnuson, S.(2017) J Med Chem 60: 9162-9183
- PubMed: 28892380 
- DOI: 10.1021/acs.jmedchem.7b00796
- Primary Citation of Related Structures:  
5W0F, 5W0I, 5W0L, 5W0Q - PubMed Abstract: 
Inhibition of the bromodomain of the transcriptional regulator CBP/P300 is an especially interesting new therapeutic approach in oncology. We recently disclosed in vivo chemical tool 1 (GNE-272) for the bromodomain of CBP that was moderately potent and selective over BRD4(1) ...